INDEPENDENT PEPTIDE EDUCATION · UPDATED WEEKLY · NOT FOR SALE TO THE PUBLIC
Home / Peptides / GHK-Cu
Skin & regenerative peptide

GHK-Cu, explained without the hype

It's the copper peptide in half the "anti-aging" serums on the shelf — and increasingly sold as a research-use injectable. Those are two very different things. Here's what GHK-Cu actually is, what the science does and doesn't show, and exactly where it stands with the FDA in 2026.

Type
Peptide
Copper tripeptide-1 (GHK-Cu)
Derived from
GHK + copper
Tripeptide bound to a copper ion
FDA status
Not approved (injectable)
Topical cosmetic use generally OK
Commonly cited dose
~1–2 mg/day
Injectable · suggestion, not approved

What is GHK-Cu?

GHK-Cu is a copper peptide — the tripeptide glycyl-L-histidyl-L-lysine (GHK) bound to a copper ion. On cosmetic ingredient labels it's listed as copper tripeptide-1. It occurs naturally in human plasma and has been studied for decades for its role in wound healing and skin remodeling. It is not a vitamin, a supplement, or an approved injectable medication.

The single most important thing to understand about GHK-Cu is that there are two completely different use cases, and people constantly blur them:

  • Topical (cosmetic): GHK-Cu is a long-established, widely-used ingredient in serums and creams, with a substantial body of research behind its topical use for skin appearance. This use is generally accepted as a cosmetic.
  • Injectable (research-use-only): The injectable form is not FDA-approved, has thin human clinical evidence, and is commonly sold labeled "research use only — not for human use."

When marketing talks about "GHK-Cu benefits," it almost always borrows the credibility of the topical research to sell the unproven injectable. That gap is exactly what this page exists to close.

It depends entirely on the form:

  • As a topical cosmetic (copper tripeptide-1 in skincare), GHK-Cu is widely sold and its cosmetic use is generally permitted.
  • As an injectable, GHK-Cu is not an FDA-approved drug. It was reportedly removed from the FDA's Category 1 listing after a withdrawn nomination, so it is currently unlisted on the compounding lists.

Want the live picture? Our regulatory-status tracker shows exactly where GHK-Cu and other peptides stand right now, with the dated primary sources.

What the research actually shows

For topical use, there is a substantial and long-standing body of research on copper peptides in skin, including studies on penetration through the skin layers and effects on skin appearance and remodeling. This is the strongest part of the GHK-Cu evidence base — and it is specifically about applying it to the skin.

For injectable or systemic use, the picture is far thinner: there is currently no rigorous clinical evidence supporting subcutaneous GHK-Cu for cosmetic skin rejuvenation in humans, and broad "anti-aging" or "regenerative" claims for the injectable run well ahead of the data. Treat confident before-and-after claims about injected copper peptides with skepticism.

Dosage & how it's reconstituted

For the injectable form, commonly reported subcutaneous doses sit around 1–2 mg per day. Worth keeping straight: topical cosmetic GHK-Cu is a separate, concentration-based use set by the product formulation — not an injected mg dose — so don't carry these numbers over to a serum. And to be clear about the injectable figures: these are not approved or standardized doses — they reflect what clinics and the wider community commonly report using today, shared for education, not medical advice. Any decision about a research-use-only injectable belongs with a licensed provider.

If a research-use-only powder is reconstituted at all, it ships freeze-dried (lyophilized) and must be mixed with bacteriostatic water — and the concentration math trips a lot of people up. If you need to understand that math, our free tool handles it:

Reconstitution & draw calculator

Enter the vial and your numbers → exact concentration and units to draw.

Open the calculator →

Side effects & safety

For the topical cosmetic form, copper peptides are generally well tolerated, with occasional mild skin irritation reported. For the injectable research-use-only form, human safety data is limited and long-term safety in humans is simply not well established. Because much of the injectable supply is research-use-only and unregulated, purity, sterility, copper content, and accurate labeling are real concerns — which is why sourcing and testing matter as much as the molecule itself.

How to do this responsibly

For topical skincare, follow the product's directions like any cosmetic. If you're considering anything beyond that — the injectable research-use-only form — the responsible path runs through a licensed provider who can weigh your situation, not a checkout page. Questions worth asking: Is there third-party testing and a certificate of analysis? What's the source and is it disclosed? Are we talking about a cosmetic or an unapproved injectable? This isn't legal or medical advice — it's the baseline diligence any unapproved substance deserves.

Frequently asked questions

Is topical GHK-Cu the same as injectable GHK-Cu?

It's the same molecule but a completely different use case and regulatory status. Topical copper tripeptide-1 is an accepted cosmetic ingredient; injectable GHK-Cu is research-use-only and not FDA-approved. Don't treat the topical research as if it validates injecting it.

Is GHK-Cu banned by WADA?

GHK-Cu is not currently listed on the World Anti-Doping Agency (WADA) Prohibited List. That is separate from FDA approval — "not banned in sport" does not mean "approved as a medicine." Verify for your situation.

Is copper tripeptide-1 in my skincare safe?

Copper tripeptide-1 is a widely-used cosmetic ingredient and is generally well tolerated topically. That cosmetic use is distinct from the unapproved injectable form discussed on this page.

Where can I buy GHK-Cu?

Topical copper-peptide serums are sold as ordinary cosmetics. We don't sell peptides and we don't direct consumers to buy unapproved injectable substances. If a licensed provider determines an injectable is appropriate, sourcing and testing should be part of that conversation.

Sources

  1. U.S. FDA — Bulk Drug Substances Used in Compounding Under Section 503A of the FD&C Act. fda.gov
  2. Pickart L, et al. — Human skin penetration of a copper tripeptide in vitro as a function of skin layer (PMC). ncbi.nlm.nih.gov
  3. Innerbody — "GHK-Cu Peptide: benefits, side effects, and more (2026)." innerbody.com
  4. Peptide Pulse — live peptide regulatory-status tracker. View tracker

Educational information only. Not medical, legal, or regulatory advice, not a dosing, treatment, or efficacy claim, and not a recommendation to obtain or use any substance. Many peptides are not FDA-approved; some are labeled research-use-only ("not for human use"). Regulatory status changes frequently — verify independently and consult a licensed provider before any health decision. Published by Health Pro Distributors. © 2026.